Role of macrophages in the candidacidal activity of liposomal amphotericin B

被引:9
作者
Mehta, RT [1 ]
Poddar, S [1 ]
Kalidas, M [1 ]
GomezFlores, R [1 ]
Dulski, K [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
关键词
D O I
10.1093/infdis/175.1.214
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of macrophage activation in the candidacidal activity of liposome-incorporated (L) amphotericin B was investigated. Macrophages treated with L-amphotericin B killed Candida albicans more effectively than did macrophages treated with free (F) amphotericin B. However, macrophages treated with neither F- nor L-amphotericin B killed amphotericin B-resistant Candida tropicalis. In vivo stimulation of macrophages by intraperitoneal administration of thioglycollate, Freund's complete adjuvant, or heat-killed C. albicans followed by in vitro treatment with F- or L-amphotericin B, did nor enhance their candidacidal activity. intravenous administration of F- or L-amphotericin B did not augment the candidacidal activity of macrophages sensitized in vivo; however, sensitized macrophages showed enhanced killing compared with resident unstimulated cells. These studies suggest that macrophage-mediated enhancement of C. albicans killing mag he due to uptake, transport, and delivery of L-amphotericin B to infected sites rather than to macrophage activation.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 15 条
  • [1] DIFFERENTIAL SUSCEPTIBILITY OF YEAST AND HYPHAL FORMS OF CANDIDA-ALBICANS TO MACROPHAGE-DERIVED NITROGEN-CONTAINING COMPOUNDS
    BLASI, E
    PITZURRA, L
    PULITI, M
    CHIMIENTI, AR
    MAZZOLLA, R
    BARLUZZI, R
    BISTONI, F
    [J]. INFECTION AND IMMUNITY, 1995, 63 (05) : 1806 - 1809
  • [2] AMPHOTERICIN-B INDUCES TUMOR NECROSIS FACTOR PRODUCTION BY MURINE MACROPHAGES
    CHIA, JKS
    POLLACK, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) : 113 - 116
  • [3] A RAPID [H-3] GLUCOSE INCORPORATION ASSA FOR DETERMINATION OF LYMPHOID CELL-MEDIATED INHIBITION OF CANDIDA-ALBICANS GROWTH
    DJEU, JY
    PARAPANISSIOS, A
    HALKIAS, D
    FRIEDMAN, H
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 92 (01) : 73 - 77
  • [4] Lipid formulations of amphotericin B: Recent progress and future directions
    Hiemenz, JW
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 : S133 - S144
  • [5] Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase
    Lefkowitz, SS
    Gelderman, MP
    Lefkowitz, DL
    Moguilevsky, N
    Bollen, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) : 1202 - 1207
  • [6] TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS WITH LIPOSOMAL AMPHOTERICIN-B
    LOPEZBERESTEIN, G
    BODEY, GP
    FAINSTEIN, V
    KEATING, M
    FRANKEL, LS
    ZELUFF, B
    GENTRY, L
    MEHTA, K
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) : 2533 - 2536
  • [7] MEHTA R, 1985, INFECT IMMUN, V147, P429
  • [8] MEHTA R T, 1989, Advanced Drug Delivery Reviews, V3, P283, DOI 10.1016/0169-409X(89)90025-2
  • [9] PHAGOCYTE TRANSPORT AS MECHANISM FOR ENHANCED THERAPEUTIC ACTIVITY OF LIPOSOMAL AMPHOTERICIN-B
    MEHTA, RT
    MCQUEEN, TJ
    KEYHANI, A
    LOPEZBERESTEIN, G
    [J]. CHEMOTHERAPY, 1994, 40 (04) : 256 - 264
  • [10] INVITRO EFFECTS OF LIPOSOME-ENCAPSULATED AMPHOTERICIN-B (AMBISOME) AND AMPHOTERICIN B-DEOXYCHOLATE (FUNGIZONE) ON THE PHAGOCYTIC AND CANDIDACIDAL FUNCTION OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    PALLISTER, CJ
    JOHNSON, EM
    WARNOCK, DW
    ELLIOT, PJ
    REEVES, DF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (03) : 313 - 320